Literature DB >> 25692402

Induction of STAT3-Dependent CXCL5 Expression and Neutrophil Recruitment by Oncostatin-M during Pneumonia.

Katrina E Traber1,2, Kristie L Hilliard1,3, Eri Allen1, Gregory A Wasserman1,3, Kazuko Yamamoto1,4, Matthew R Jones1,2, Joseph P Mizgerd1,2,3,5, Lee J Quinton1,2,6.   

Abstract

Acute bacterial pneumonia is a significant public health concern worldwide. Understanding the signals coordinating lung innate immunity may foster the development of therapeutics that limit tissue damage and promote host defense. We have previously shown that lung messenger RNA expression of the IL-6 family cytokine oncostatin-M (OSM) is significantly elevated in response to bacterial stimuli. However, its physiological significance during pneumonia is unknown. Here we demonstrate that OSM is rapidly increased in the airspaces of mice after pulmonary infection with Escherichia coli. Neutralization of OSM caused a substantial decrease in airspace neutrophils and macrophages. OSM blockade also caused a marked reduction in lung chemokine (C-X-C motif) ligand (CXCL) 5 expression, whereas other closely related neutrophil chemokines, CXCL1 and CXCL2, were unaffected. Intratracheal administration of recombinant OSM was sufficient to recapitulate the effect on CXCL5 induction, associated with robust activation of the signal transducer and activator of transcription 3 (STAT3) transcription factor. Cell sorting revealed that OSM effects were specific to lung epithelial cells, including a positive feedback loop in which OSM may facilitate expression of its own receptor. Finally, in vitro studies demonstrated that STAT3 was required for maximal OSM-induced CXCL5 expression. These studies demonstrate a novel role for OSM during pneumonia as an important signal to epithelial cells for chemokine induction mediating neutrophil recruitment.

Entities:  

Keywords:  CXCL5; STAT3; macrophage; neutrophil; oncostatin-M; pneumonia

Mesh:

Substances:

Year:  2015        PMID: 25692402      PMCID: PMC4742898          DOI: 10.1165/rcmb.2014-0342OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  43 in total

Review 1.  Oncostatin M: foe or friend?

Authors:  Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Arthritis Rheum       Date:  2003-12

2.  Cytokine networks in the infected lung.

Authors:  Urvashi Bhan; Matthew D Cornicelli; Theodore J Standiford
Journal:  Expert Rev Respir Med       Date:  2008-12       Impact factor: 3.772

3.  Oncostatin M production by blood and alveolar neutrophils during acute lung injury.

Authors:  A Grenier; D Combaux; J Chastre; M A Gougerot-Pocidalo; C Gibert; M Dehoux; S Chollet-Martin
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

4.  NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.

Authors:  A Wuyts; A D'Haese; V Cremers; P Menten; J P Lenaerts; A De Loof; H Heremans; P Proost; J Van Damme
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice.

Authors:  Lee J Quinton; Matthew T Blahna; Matthew R Jones; Eri Allen; Joseph D Ferrari; Kristie L Hilliard; Xiaoling Zhang; Vishakha Sabharwal; Hana Algül; Shizuo Akira; Roland M Schmid; Stephen I Pelton; Avrum Spira; Joseph P Mizgerd
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 6.  Hospital-acquired infections due to gram-negative bacteria.

Authors:  Anton Y Peleg; David C Hooper
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

7.  CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs.

Authors:  Shanshan Cai; Sanjay Batra; Sergio A Lira; Jay K Kolls; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2010-10-11       Impact factor: 5.422

8.  Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia.

Authors:  Kazuko Yamamoto; Joseph D Ferrari; Yuxia Cao; Maria I Ramirez; Matthew R Jones; Lee J Quinton; Joseph P Mizgerd
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis.

Authors:  Afsaneh Mozaffarian; Avery W Brewer; Esther S Trueblood; Irina G Luzina; Nevins W Todd; Sergei P Atamas; Heather A Arnett
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Leukemia inhibitory factor signaling is required for lung protection during pneumonia.

Authors:  Lee J Quinton; Joseph P Mizgerd; Kristie L Hilliard; Matthew R Jones; Candice Y Kwon; Eri Allen
Journal:  J Immunol       Date:  2012-05-11       Impact factor: 5.422

View more
  16 in total

1.  IL-17 Receptor Signaling in the Lung Epithelium Is Required for Mucosal Chemokine Gradients and Pulmonary Host Defense against K. pneumoniae.

Authors:  Kong Chen; Taylor Eddens; Giraldina Trevejo-Nunez; Emily E Way; Waleed Elsegeiny; David M Ricks; Abhishek V Garg; Carla J Erb; Meihua Bo; Ting Wang; Wei Chen; Janet S Lee; Sarah L Gaffen; Jay K Kolls
Journal:  Cell Host Microbe       Date:  2016-10-27       Impact factor: 21.023

2.  Neutrophil-Derived Oncostatin M Triggers Diverse Signaling Pathways during Pneumonia.

Authors:  Katrina E Traber; Ernest L Dimbo; Anukul T Shenoy; Elise M Symer; Eri Allen; Joseph P Mizgerd; Lee J Quinton
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

3.  NF-κB RelA Is Required for Hepatoprotection during Pneumonia and Sepsis.

Authors:  Yuri Kim; Eri Allen; Lillia A Baird; Elise M Symer; Filiz T Korkmaz; Elim Na; Christine V Odom; Matthew R Jones; Joseph P Mizgerd; Katrina E Traber; Lee J Quinton
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

4.  Myeloid-epithelial cross talk coordinates synthesis of the tissue-protective cytokine leukemia inhibitory factor during pneumonia.

Authors:  Katrina E Traber; Elise M Symer; Eri Allen; Yuri Kim; Kristie L Hilliard; Gregory A Wasserman; Colin L Stewart; Matthew R Jones; Joseph P Mizgerd; Lee J Quinton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

5.  Pneumonia recovery reprograms the alveolar macrophage pool.

Authors:  Antoine Guillon; Emad I Arafa; Kimberly A Barker; Anna C Belkina; Ian Martin; Anukul T Shenoy; Alicia K Wooten; Carolina Lyon De Ana; Anqi Dai; Adam Labadorf; Jaileene Hernandez Escalante; Hans Dooms; Hélène Blasco; Katrina E Traber; Matthew R Jones; Lee J Quinton; Joseph P Mizgerd
Journal:  JCI Insight       Date:  2020-02-27

6.  Epithelial LIF signaling limits apoptosis and lung injury during bacterial pneumonia.

Authors:  Elim Na; Eri Allen; Lillia A Baird; Christine V Odom; Filiz T Korkmaz; Anukul T Shenoy; Adeline M Matschulat; Matthew R Jones; Darrell N Kotton; Joseph P Mizgerd; Xaralabos Varelas; Katrina E Traber; Lee J Quinton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-02-09       Impact factor: 6.011

7.  Integrative analysis reveals mouse strain-dependent responses to acute ozone exposure associated with airway macrophage transcriptional activity.

Authors:  Adelaide Tovar; Wesley L Crouse; Gregory J Smith; Joseph M Thomas; Benjamin P Keith; Kathryn M McFadden; Timothy P Moran; Terrence S Furey; Samir N P Kelada
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-11-10       Impact factor: 6.011

Review 8.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

9.  Treponema denticola stimulates Oncostatin M cytokine release and de novo synthesis in neutrophils and macrophages.

Authors:  Megan M Jones; Stephen T Vanyo; Wael Ibraheem; Abhiram Maddi; Michelle B Visser
Journal:  J Leukoc Biol       Date:  2020-07-17       Impact factor: 4.962

10.  Functional Evidence of Pulmonary Extracellular Vesicles in Infectious and Noninfectious Lung Inflammation.

Authors:  Heedoo Lee; Duo Zhang; Debra L Laskin; Yang Jin
Journal:  J Immunol       Date:  2018-07-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.